Back to ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC

All holdings · as of Dec 31, 2025

249 positions

CompanyClassValueShares% of portfolio
Aclaris Therapeutics, Inc.$1.85M613,9860.1%
PFIZER INC$1.80M72,4000.1%
BioAge Labs, Inc.BIOACommon Stock$1.79M135,5600.1%
Alkermes plc.$1.78M63,7000.1%
Globus Medical Inc$1.75M20,1000.1%
Alector, Inc.$1.73M1,108,0000.1%
ROCKET PHARMACEUTICALS, INC.$1.67M475,8000.1%
WW INTERNATIONAL, INC.$1.67M57,1000.1%
Summit Therapeutics Inc.SMMTCommon Stock$1.61M91,8690.1%
COHEN CIRCLE ACQUISIT CORP I$1.56M150,0000.1%
Supernus Pharmaceuticals Inc$1.48M29,7420.1%
Inspire Medical Systems, Inc.$1.38M15,0000.1%
Nurix Therapeutics, Inc.$1.37M72,0700.1%
Jazz Pharmaceuticals PLC$1.36M8,0000.1%
OmniAb, Inc.OABICommon Stock$1.30M702,1900.1%
Tango Therapeutics, Inc.$1.24M140,0210.1%
Adagio Medical Holdings, Inc.$1.21M1,159,6140.1%
Kiniksa Pharmaceuticals International, plc$1.19M28,7280.1%
SPYRE THERAPEUTICS, INC.$1.12M34,0510.1%
Adicet Bio, Inc.$1.08M128,6460.1%
BRISTOL MYERS SQUIBB CO$1.08M20,0000.1%
Tenaya Therapeutics, Inc.TNYACommon Stock$1.07M1,505,3000.1%
Best SPAC I Acquisition Corp.$1.02M100,0000.1%
Merck & Co., Inc.$1.01M9,6400.1%
CHURCHILL CAP CORP X$1.01M64,8870.1%
ELECTRONIC ARTS INC.$1.01M4,9360.1%
MCKESSON CORP$984.3K1,2000.1%
CENTESSA PHARMACEUTICALS PLC$964.5K38,5660.1%
BioNTech SEBNTXADR$952.0K10,0000.1%
Viking Therapeutics Inc$932.1K26,4940.1%
United Therapeutics Corp$925.8K1,9000.1%
PLYMOUTH INDUSTRIAL REIT INCPLYMREIT$898.5K41,0650.1%
4D MOLECULAR THERAPEUTICS, INC.$875.3K116,7120.1%
Denali Therapeutics Inc.$860.4K52,1160.1%
Xencor Inc$859.9K56,1650.1%
Kalaris Therapeutics, Inc.KLRSCommon Stock$844.0K100,0000.1%
Quoin Pharmaceuticals Ltd.$840.3K58,2300.1%
Dyne Therapeutics, Inc.$834.7K42,6740.1%
ASTRAZENECA PLC$827.4K9,0000.1%
GILEAD SCIENCES, INC.$818.2K6,6660.1%
Avantor, Inc.$802.2K70,0000.1%
Alexandria Real Estate Equities Inc$797.7K16,3000.1%
Pulmonx Corp$785.5K355,4100.1%
iBio, Inc.IBIOCommon Stock$782.7K405,5310.1%
Tenax Therapeutics, Inc.$776.2K63,6730.1%
Sutro Biopharma, Inc.$776.1K67,0770.1%
BioMarin Pharmaceutical Inc$766.6K12,9000.1%
Compass Therapeutics, Inc.$746.4K139,0000.1%
Vera Therapeutics, Inc.$746.1K14,7330.1%
KEZAR LIFE SCIENCES INC$738.7K117,4400.1%
← PrevPage 3 of 5Next →